| 查看: 3695 | 回复: 54 | |||||||||||||||||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||||||||||||||||
[交流]
清华大学深圳 生物医药与健康工程研究院 Tsuboi课题组诚聘博士后
|
|||||||||||||||||
The Tsuboi laboratory at the Tsinghua-Shenzhen is recruiting opening postdoctoral members who are interested in RNA, mitochondria, or aging research (from September). We focused on understanding how the cellular organization controls gene regulation and age-related processes such as cancer and neurodegenerative diseases. We believe our quantitative approach combining microscopy, computational modeling, and biochemistry will discover anti-aging drugs in the long run. We are recruiting 2 postdocswho are interested in our research topics or techniques. For more information, please see my homepage (https://www.tsuboilab.com/). Please don’t hesitate to send me an e-mail if you are interested (tsuboitat(at)hotmail.com). The base salary starts from 330,000 RMB ($50,000) and you will have more opportunities in external fundings. On a side note, the Tsinghua-Shenzhen, Shenzhen government, and we support incoming postdocs very generously. For domestic Ph.D. students, We are aware that because of the COVID-19 restriction, many excellent students cannot move overseas for postdoctoral experience, but our lab will run in English and may cover what you are expected for your postdoctoral period. We can also support you to move to your next career in the future. Cheers!! 待遇薪资优厚,位置有限,请尽快发简历到我邮箱(tsuboitat@hotmail.com )联系我! [ 来自版块群 广东 ] |
» 猜你喜欢
售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急
已经有4人回复
售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急
已经有5人回复
售一区SCI文章T0P,我:8O.551.O54,科目全,可十急
已经有3人回复
售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急
已经有4人回复
售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急
已经有6人回复
售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急
已经有3人回复
售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急
已经有3人回复
售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急
已经有3人回复
售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急
已经有4人回复
售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急
已经有3人回复
★
Tsuboi_Lab(金币+1): 谢谢参与
Tsuboi_Lab(金币+1): 谢谢参与
|
本帖内容被屏蔽 |
42楼2026-08-17 21:57:55
2楼2021-07-02 15:41:24
3楼2021-07-03 17:52:41
4楼2021-07-04 02:38:30










回复此楼